Ceftaroline for the treatment of methicillin-resistantStaphylococcus aureusbacteremia
Author:
Affiliation:
1. OU Medical Center, Oklahoma City, OK
2. University of Mississippi School of Pharmacy, Jackson, MS
Publisher
Oxford University Press (OUP)
Subject
Health Policy,Pharmacology
Link
http://academic.oup.com/ajhp/article-pdf/74/4/201/28336933/ajhp0201.pdf
Reference55 articles.
1. The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals;Kaye;Clin Infect Dis,2008
2. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand;Turnidge;Med J Aust,2009
3. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study;Murray;Clin Infect Dis,2013
4. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists;Rybak;Am J Health-Syst Pharm,2009
5. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial;Bosso;Antimicrob Agents Chemother,2011
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ceftaroline Fosamil for the Treatment of Methicillin-Resistant Staphylococcus Aureus Bacteremia: A Real-World Comparative Clinical Outcomes Study;Drugs - Real World Outcomes;2024-04-02
2. Antimicrobial Drug Penetration is Enhanced by Lung Tissue Inflammation and Injury;American Journal of Respiratory and Critical Care Medicine;2023-12-15
3. Anti Bacterial Drugs: A Bright Past but a Challenging Future;Current Trends in the Identification and Development of Antimicrobial Agents;2023-03-07
4. Escalation of antimicrobial resistance among MRSA part 2: focus on infections and treatment;Expert Review of Anti-infective Therapy;2022-12-12
5. Ceftaroline: Systematic Review of Clinical Uses and Emerging Drug Resistance;Annals of Pharmacotherapy;2022-03-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3